Navigation Links
Diagnosoft(R) Secures $4 Million in Financing and Appoints a New President and CEO
Date:1/29/2009

MORRISVILLE, N.C. and PALO ALTO, Calif., Jan. 29 /PRNewswire/ -- Diagnosoft, Inc., an innovator in magnetic resonance (MR) image analysis software that assists in diagnosis, staging and therapeutic monitoring of cardiovascular disease, has announced the closing of $4 million in Series B financing led by Technology Development Fund (TDF) of Cairo, Egypt. The company intends to use the new capital to support further market expansion of Diagnosoft(R) HARP(TM), Diagnosoft(R) PLUS, and Diagnosoft(R) SENC. The capital infusion will also serve to further the development of other innovative MR image analysis technologies designed to increase physician productivity and accuracy, improve patient outcomes, and enhance research and drug development advances.

"When cardiologists and radiologists can make a decision about the condition of a patient's heart based on quantitative data obtained from cardiac MRI analysis, rather than just 'eyeballing' images," said Diagnosoft Co-Founder Dr. Matthias Stuber, "they can come to a faster conclusion that's substantiated, not subjective. When diagnosis and treatment is supported by the numerical data our software provides, it's stronger from a legal standpoint as well."

According to Dr. Jerry Prince, Diagnosoft co-founder and colleague of Dr. Stuber at Johns Hopkins University, "There are many techniques for analyzing the left ventricle of the heart -- ECHO, nuclear medicine, CT, and so -- but we are focused on the emerging technology of MRI for the cardiac market. We are kind of a one-stop shop for innovative analysis of the four magnetic resonance imaging techniques -- CINE, perfusion, delayed enhancement or viability, and function or strain. Diagnosoft is the only company directly looking at function, to see if the heart muscle is contracting properly; consequently, we are the only ones who can put all four imaging techniques together, and present it to the
'/>"/>

SOURCE Diagnosoft, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
2. Simplex Diabetic Supply, Inc. Secures $50 Million in Growth Equity from New Enterprise Associates
3. UI licensee Optherion secures $37 million in financing
4. IPS Secures National Contract to Deliver FOCUS Healthcare Provider Network Access to Pain Management Specialists
5. Piedmont Pharmaceuticals Secures $8.5 Million Investment
6. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
7. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
8. Senetek PLC Announces North American Partner for Invicorp(R) Secures Financing for Advancement of Marketing and Development Efforts
9. SpectraScience Secures Distribution for WavSTAT(R) System in Czech Republic
10. InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group
11. Asoyia Secures Venture Capital Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... PA (PRWEB) May 30, 2015 You've probably ... cause injury and hearing loss. However, have you found a ... wife from Olathe, Kan., have exactly what you need. , ... removing wax build-up; dirt and dead, dry skin from the ... standard cotton swabs or anything on the market today for ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 Promising clinical ... Oncology (ASCO) Annual Meeting 2015 show activity of the ... one case specifically against brain metastases and in another ... cancer patients. , "I am thrilled to have been ... her early 40s. She didn't have any other great ...
(Date:5/30/2015)... Houston, Texas (PRWEB) May 30, 2015 ... week for 2015’s Aesthetic Meeting, sponsored by the American ... many industry vendors on hand was Zeltiq, the parent ... the aesthetic space, CoolSculpting. With blazing growth, the ... , Zeltiq is currently in the ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 NovaSure® endometrial ... lighten or stop periods, without the side effects ... can reduce or stop menstrual bleeding and works by ... (the part that causes the bleeding), with a quick ... suffer from heavy menstrual bleeding. Many women begin ...
(Date:5/30/2015)... NC (PRWEB) May 30, 2015 The ... that crocidolite asbestos has a high potential to cause ... the full story now on the Surviving Mesothelioma ... Institute of Occupational Medicine in Lodz, Poland found that, ... asbestos workers between 1970 and 2012, all of them ...
Breaking Medicine News(10 mins):Health News:Improved Ear Hygiene Tool Invented by InventHelp Clients (KSC-952) 2Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 2Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 3Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 2Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 3Health News:Women's Excellence Now Provides NovaSure Treatment 2Health News:New Study Finds Close Link Between Crocidolite Asbestos and Deadly Mesothelioma, According to Surviving Mesothelioma 2
... A unique study conducted by researchers at University of California ... children in the U.S. reveals that it is much higher ... warned about the possibility of back pain as a result ... more than 7000 school-going children present in the emergency room ...
... There is another feather in the coffee cap proposed by ... which says that drinking a cup of coffee with 100 ... procedure for the study involved 15 healthy men aged 26 ... caffeine and then when they consumed a placebo. 100 mg ...
... at preventing amputations and other disease-related complications in diabetics ... State of Tamil Nadu, courtesy a hospital initiative//. ... Initiative in the Community (DAPIC)" programme at Maragal Kandigai ... as a boon. DAPIC seeks to prevent diabetic foot ...
... activity in children's with autism and found that ... The Researchers found //that the autism children's had less ... and imitating others action and expressing facial response. The ... Neuroscience. ,Autism is a developmental disorder that ...
... executed prisoners being sold to foreigners for human transplantation ... Chinese health officials, who have been passive// about the ... widespread prevalence of such an inhuman act. ... from total strangers (were paid for their donation) and ...
... outbreak was detected in Ukraine (Crimea peninsula) and hence domestic ... for the purpose//. Health workers and emergency workers are recruited ... ducks and geese) and destroy them thereby the outbreak can ... bird that was killed. ,Various other ...
Cached Medicine News:Health News:Widespread Commercialisation Of Human Organ Donation In China 2
(Date:5/30/2015)... , May 30, 2015  Eisai Inc. announced today the ... that eribulin met the study,s primary endpoint evaluating overall survival ... (ADI), two types of advanced soft tissue sarcoma. These data ... of the American Society of Clinical Oncology (ASCO) in ... conference on Saturday, May 30, and also in an oral ...
(Date:5/30/2015)... May 30, 2015 Caris Life Sciences®, ... promise of precision medicine, today announced the presentation ... utility of Caris Molecular Intelligence®, the company,s panomic ... tumors that share histological features. In separate presentations ... of Clinical Oncology (ASCO) in Chicago, ...
(Date:5/29/2015)... - Alliance Principle Ingredients/Neutrical Solutions Inc., in consultation with ... Health Ginger in Bentonite (NPN 80053535) due to ... The product currently contains levels of lead beyond ... for adult dosing. Ginger in Bentonite ... Alliance Principle Ingredients / Neutrical Solutions Inc. has ...
Breaking Medicine Technology:Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 2Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 3Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 4Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 5Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 6Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 2Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 3Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 4Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 5Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 6
... The DataMate Laser ... System consists of laser-printable ... closure wristband and laser ... paperwork. The wristbands clear, ...
Use these popular insert style bands to secure a bar code label inside the wristband pocket for maximum convenience and security....
... PDCs computer-generated Thermal Printing Wristbands and ... direct thermal and thermal transfer printers. ... activate a heat-sensitive thermal coating under ... printers use heat to transfer highly ...
... Designed for use in ... Alzheimer units, where you may ... which is easy to apply ... The band's width is increased ...
Medicine Products: